A detailed history of Geode Capital Management, LLC transactions in Evoke Pharma Inc stock. As of the latest transaction made, Geode Capital Management, LLC holds 49,691 shares of EVOK stock, worth $23,354. This represents 0.0% of its overall portfolio holdings.

Number of Shares
49,691
Previous 27,065 83.6%
Holding current value
$23,354
Previous $16,000 62.5%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$0.43 - $0.62 $9,729 - $14,028
22,626 Added 83.6%
49,691 $26,000
Q3 2023

Nov 13, 2023

BUY
$0.96 - $1.73 $5,924 - $10,675
6,171 Added 29.53%
27,065 $37,000
Q2 2022

Aug 12, 2022

BUY
$2.04 - $10.32 $42,623 - $215,626
20,894 New
20,894 $67,000

Others Institutions Holding EVOK

About Evoke Pharma Inc


  • Ticker EVOK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,343,070
  • Market Cap $1.57M
  • Description
  • Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray that has completed Phase 3 clinical trials to treat symptoms associated with acute and recurrent diabeti...
More about EVOK
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.